Literature DB >> 4131854

Serum alpha-fetoprotein levels in acute viral hepatitis.

M C Kew, L R Purves, I Bersohn.   

Abstract

Serum alpha-fetoprotein levels were measured serially by radioimmunoassay in 32 patients with acute viral hepatitis. With one exception, the levels were increased during the course of the illness. Raised concentrations of the protein occurred almost equally in patients with and without the hepatitis-B antigen. In the majority of patients the rise was modest but in seven levels were reached at which alpha-fetoprotein could be detected by immunodiffusion. Very high levels were more likely to occur in children. In eight patients the concentration increased as the serum glutamic pyruvic transaminase (SGPT) level, used as an index of hepatocyte damage, was returning to normal, a pattern which favoured increased synthesis of the protein during hepatocellular regeneration. In the remainder, the alpha-fetoprotein level paralleled that of SGPT, suggesting rather an acutephase reaction to liver injury.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4131854      PMCID: PMC1412874          DOI: 10.1136/gut.14.12.939

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  -Foetoprotein in normal human serum.

Authors:  E Ruoslahti; M Seppälä
Journal:  Nature       Date:  1972-01-21       Impact factor: 49.962

2.  Normal and increased alpha-fetoprotein in neoplastic and non-neoplastic liver disease.

Authors:  E Ruoslahti; M Seppälä
Journal:  Lancet       Date:  1972-08-05       Impact factor: 79.321

3.  Serum alpha-feto-protein. VI. The radio-immunoassay evidence for the presence of AFP in the serum of normal people and during pregnancy.

Authors:  L R Purves; M Purves
Journal:  S Afr Med J       Date:  1972-09-09

4.  Alpha-fetoprotein in acute viral hepatitis.

Authors:  T Akeyama; T Koyama; T Kamada
Journal:  N Engl J Med       Date:  1972-11-09       Impact factor: 91.245

Review 5.  Alpha-fetoprotein in ontogenesis and its association with malignant tumors.

Authors:  G I Abelev
Journal:  Adv Cancer Res       Date:  1971       Impact factor: 6.242

6.  Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma.

Authors:  C L Vogel; P P Anthony; N Mody; L F Barker
Journal:  Lancet       Date:  1970-09-26       Impact factor: 79.321

7.  Serum protein changes during the acute phase reaction.

Authors:  M Werner
Journal:  Clin Chim Acta       Date:  1969-08       Impact factor: 3.786

8.  Occurrence of alpha-fetoprotein in acute viral hepatitis.

Authors:  J B Smith
Journal:  Int J Cancer       Date:  1971-11-15       Impact factor: 7.396

9.  Rapid detection of Australia antigen by counterimmunoelectrophoresis.

Authors:  D J Gocke; C Howe
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

10.  A complement-fixation test for measuring Australia antigen and antibody.

Authors:  R H Purcell; P V Holland; J H Walsh; D C Wong; A G Morrow; R M Chanock
Journal:  J Infect Dis       Date:  1969-09       Impact factor: 5.226

View more
  12 in total

Review 1.  [Carcinofetal antigens. I. alpha-fetoprotein (author's transl)].

Authors:  R Lamerz; A Fateh-Moghadam
Journal:  Klin Wochenschr       Date:  1975-02-15

2.  [Variations of human serum alpha-fetoprotein concentration after partial hepatectomy (author's transl)].

Authors:  R Lamerz; J Grunst; A Fatch-Moghadam; U Schmalhorst; H Pichlmaier; J Eisenburg
Journal:  Klin Wochenschr       Date:  1975-02-01

Review 3.  Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china.

Authors:  Peipei Song; Jianjun Gao; Yoshinori Inagaki; Norihiro Kokudo; Kiyoshi Hasegawa; Yasuhiko Sugawara; Wei Tang
Journal:  Liver Cancer       Date:  2013-01       Impact factor: 11.740

4.  Editorial: Towards an artificial liver.

Authors: 
Journal:  Br Med J       Date:  1974-09-14

5.  Reciprocal changes in serum albumin and alpha-fetoprotein levels in the recovery course of acute viral hepatitis stimulated by glucagon and insulin therapy: analysis of a double blind controlled trial.

Authors:  K Fujiwara; I Ogata; H Oka
Journal:  Gastroenterol Jpn       Date:  1989-04

6.  Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus.

Authors:  Takashi Kumada; Hidenori Toyoda; Seiki Kiriyama; Makoto Tanikawa; Yasuhiro Hisanaga; Akira Kanamori; Toshifumi Tada; Junko Tanaka; Hiroshi Yoshizawa
Journal:  J Gastroenterol       Date:  2010-12-07       Impact factor: 7.527

7.  Serum alpha-fetoprotein in patients following partial hepatectomy.

Authors:  N Nagasue; K Inokuchi; M Kobayashi; R Kanashima
Journal:  Dig Dis Sci       Date:  1980-04       Impact factor: 3.199

8.  The dynamics of alpha-fetoprotein and albumin synthesis in human and rat liver during normal ontogeny.

Authors:  N C Nayak; I Mital
Journal:  Am J Pathol       Date:  1977-02       Impact factor: 4.307

9.  Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.

Authors:  N Eleftheriou; J Heathcote; H C Thomas; S Sherlock
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

10.  Differentiating hepatocellular carcinoma from hepatitis C using metabolite profiling.

Authors:  Siwei Wei; Yuliana Suryani; G A Nagana Gowda; Nicholas Skill; Mary Maluccio; Daniel Raftery
Journal:  Metabolites       Date:  2012-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.